M.C.S. Steel PCL (BKK:MCS)
Thailand · Delayed Price · Currency is THB 8.40
+0.05 (0.60%)
Aug 5, 2025, 4:38 PM ICT
Ligand Pharmaceuticals Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 5,604 | 5,607 | 5,777 | 3,988 | 6,907 | 4,252 | Upgrade |
Other Revenue | 76.18 | 79.93 | 41.92 | 26.89 | 37.32 | 32.09 | Upgrade |
| 5,680 | 5,687 | 5,819 | 4,015 | 6,944 | 4,284 | Upgrade | |
Revenue Growth (YoY) | 1.15% | -2.27% | 44.94% | -42.18% | 62.09% | 27.85% | Upgrade |
Cost of Revenue | 3,948 | 4,030 | 4,724 | 3,055 | 3,968 | 2,649 | Upgrade |
Gross Profit | 1,732 | 1,657 | 1,095 | 959.88 | 2,976 | 1,635 | Upgrade |
Selling, General & Admin | 765.51 | 818.07 | 819.55 | 785.11 | 1,307 | 465.24 | Upgrade |
Operating Expenses | 765.51 | 818.07 | 819.55 | 785.11 | 1,307 | 465.24 | Upgrade |
Operating Income | 966.62 | 838.74 | 275.47 | 174.77 | 1,669 | 1,170 | Upgrade |
Interest Expense | -22.82 | -21.15 | -36.78 | -10.73 | -17.02 | -26.01 | Upgrade |
Currency Exchange Gain (Loss) | -72.87 | -112.74 | -85.37 | 27.46 | -28.99 | -47.01 | Upgrade |
EBT Excluding Unusual Items | 870.94 | 704.85 | 153.32 | 191.5 | 1,623 | 1,097 | Upgrade |
Pretax Income | 870.94 | 704.85 | 153.32 | 191.5 | 1,623 | 1,097 | Upgrade |
Income Tax Expense | 23.21 | 14.37 | 8.73 | 56.94 | 163.44 | 107.45 | Upgrade |
Earnings From Continuing Operations | 847.73 | 690.48 | 144.6 | 134.56 | 1,459 | 989.13 | Upgrade |
Net Income to Company | 847.73 | 690.48 | 144.6 | 134.56 | 1,459 | 989.13 | Upgrade |
Minority Interest in Earnings | -18.26 | -11.87 | 20.01 | -14.69 | -43.56 | -35.05 | Upgrade |
Net Income | 829.47 | 678.6 | 164.61 | 119.87 | 1,416 | 954.08 | Upgrade |
Net Income to Common | 829.47 | 678.6 | 164.61 | 119.87 | 1,416 | 954.08 | Upgrade |
Net Income Growth | 233.00% | 312.25% | 37.33% | -91.53% | 48.39% | 56.78% | Upgrade |
Shares Outstanding (Basic) | 481 | 477 | 477 | 477 | 477 | 477 | Upgrade |
Shares Outstanding (Diluted) | 481 | 477 | 477 | 477 | 477 | 477 | Upgrade |
Shares Change (YoY) | 3.19% | - | - | - | - | - | Upgrade |
EPS (Basic) | 1.72 | 1.42 | 0.35 | 0.25 | 2.97 | 2.00 | Upgrade |
EPS (Diluted) | 1.72 | 1.42 | 0.35 | 0.25 | 2.97 | 2.00 | Upgrade |
EPS Growth | 222.72% | 312.25% | 37.33% | -91.53% | 48.39% | 56.78% | Upgrade |
Free Cash Flow | -302.18 | -152.55 | 62.49 | -206.5 | 820.3 | 322.13 | Upgrade |
Free Cash Flow Per Share | -0.63 | -0.32 | 0.13 | -0.43 | 1.72 | 0.68 | Upgrade |
Dividend Per Share | 0.700 | 0.700 | 0.320 | 0.200 | 1.270 | 1.000 | Upgrade |
Dividend Growth | 118.75% | 118.75% | 60.00% | -84.25% | 27.00% | 53.85% | Upgrade |
Gross Margin | 30.50% | 29.13% | 18.82% | 23.91% | 42.85% | 38.16% | Upgrade |
Operating Margin | 17.02% | 14.75% | 4.73% | 4.35% | 24.03% | 27.30% | Upgrade |
Profit Margin | 14.60% | 11.93% | 2.83% | 2.99% | 20.39% | 22.27% | Upgrade |
Free Cash Flow Margin | -5.32% | -2.68% | 1.07% | -5.14% | 11.81% | 7.52% | Upgrade |
EBITDA | 1,109 | 982.71 | 414.58 | 308.64 | 1,797 | 1,293 | Upgrade |
EBITDA Margin | 19.52% | 17.28% | 7.12% | 7.69% | 25.88% | 30.19% | Upgrade |
D&A For EBITDA | 142.13 | 143.97 | 139.11 | 133.87 | 128.21 | 123.55 | Upgrade |
EBIT | 966.62 | 838.74 | 275.47 | 174.77 | 1,669 | 1,170 | Upgrade |
EBIT Margin | 17.02% | 14.75% | 4.73% | 4.35% | 24.03% | 27.30% | Upgrade |
Effective Tax Rate | 2.66% | 2.04% | 5.69% | 29.73% | 10.07% | 9.80% | Upgrade |
Revenue as Reported | 5,700 | 5,687 | 5,819 | 4,042 | 6,944 | 4,284 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.